Morgan Sheng
Corporate Officer/Principal chez Massachusetts Institute of Technology
Postes actifs de Morgan Sheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Historique de carrière de Morgan Sheng
Anciens postes connus de Morgan Sheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PREVAIL THERAPEUTICS INC. | Directeur/Membre du Conseil | 15/11/2019 | 22/01/2021 |
| Independent Dir/Board Member | 15/11/2019 | 22/01/2021 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 15/09/2008 | - |
Formation de Morgan Sheng
| University of Oxford | Undergraduate Degree |
| University of London | Doctorate Degree |
| Harvard University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Morgan Sheng
- Expérience
